Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study
Piotr Krzeski, Chris Buckland-Wright, Géza Bálint…Volume:
9
Language:
english
DOI:
10.1186/ar2315
Date:
October, 2007
File:
PDF, 224 KB
english, 2007